Cover Image
市場調查報告書

免疫療法的癌症治療創新

Transforming Cancer Treatment with Immunotherapy

出版商 Technical Insights (Frost & Sullivan) 商品編碼 341078
出版日期 內容資訊 英文 51 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
免疫療法的癌症治療創新 Transforming Cancer Treatment with Immunotherapy
出版日期: 2015年09月29日 內容資訊: 英文 51 Pages
簡介

癌症免疫療法,形成現在湧進癌症治療產業的變革浪潮的一部分,這個領域在技術方面與商業用途方面都顯出相當大的進步。幾個藥物候補已經獲得FDA核准受到關注,這些對於單劑治療藥和治療補助藥都展現出非常高的效果。

本報告提供癌症治療的免疫療法的市場與技術概要、主要趨勢等。

第1章 摘要整理

第2章 癌症免疫療法概要

  • 癌症:高漲的全球性威脅
  • 癌症治療的變遷
  • 癌症免疫療法的類別
  • 產業概要 - 主要研究機關及創新企業
  • 技術藍圖

第3章 技術概要

  • 癌症免疫療法 - 基礎技術
  • 成為免疫療法對象的癌症種類
  • 癌症免疫療法現在達第三階段臨床試驗階段
  • 推動市場成長要素及阻礙因素
  • 推動市場成長要素及阻礙因素帶來的影響的評估
  • 推動市場成長要素說明
  • 阻礙市場成長要素說明
  • 免疫查核點、調製
  • PD-1免疫療法 - 革新
  • 臨床試驗資料 - 查核點、調製
  • PD-1免疫療法 - 治療通行證
  • CTLA4免疫療法 - 革新
  • 細胞免疫治療 - 類別
  • 臨床試驗資料 - 癌症疫苗
  • 癌症治療疫苗 - 類別
  • 癌症疫苗 - 革新

第4章 癌症免疫療法趨勢

  • 目前產業趨勢
  • 創業投資投資
  • 最高層的創業投資投資(2014∼2015年)
  • 企業聯盟及合作
  • 全球市場形勢
  • 全球專利公開趨勢 - 2012∼2014年
  • 各管轄地區(前20名專利局)的全球專利情形 - 2012∼2014年
  • 主要專利持有企業的競爭力基準
  • 主要聯繫處
  • 免責事項

第5章 關於Frost&Sullivan

目錄
Product Code: D6A3-01-00-00-00

Fight cancer with Immunotherapy

Cancer immunotherapy is currently part of a transformative wave that has hit the cancer treatment industry. The progress in this space has been rather substantial on both the technical and commercial front. There have been some high profile FDA approvals for drug candidates, that have shown themselves to be very effective, both as monotherapies and adjunct therapies. Cancer immunotherapy is essentially garnering one's own immune system and enabling it with the correct tools to attack and destroy the invasive tumors from within. This form of therapy will result in lesser side effects and would be more beneficial than the conventional treatment options that are there. The development of these checkpoint inhibitor treatments, cellular immune therapies, as well as cancer vaccines, is playing a crucial role in the pharmaceutical industry.

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Scope

2. CANCER IMMUNOTHERAPY SNEAK PEAK

Cancer Immunotherapy Sneak Peak

  • 1. Cancer: A growing global threat
  • 2. Care transformation across cancer
  • 3. Cancer Immunotherapy Segmentation
  • 4. Industry Overview - Main Innovators
  • 5. Technology Roadmap

3. TECHNOLOGY OVERVIEW

Technology Overview

  • 1. Cancer Immunotherapies - Platform Technologies
  • 2. Cancer Immunotherapies - Platform Technologies
  • 3. Types of Cancer Targeted by Immunotherapy
  • 4. Cancer Immunotherapies currently in Phase 3 trials
  • 5. Drivers and Restraints
  • 6. Drivers and Restraints Impact Assessment
  • 7. Drivers Explained
  • 8. Restraints Explained
  • 9. Immune Checkpoint Modulation
  • 10. PD-1 immunotherapies - Innovations
  • 11. Clinical Trial Data - Checkpoint Modulation
  • 12. PD-1 immunotherapies - Treatment Pathway
  • 13. CTLA4 immunotherapies - Innovations
  • 14. Cellular Immune Therapy - Types
  • 15. Clinical Trial Data - Cancer Vaccines
  • 16. Cancer Treatment Vaccines - Types
  • 17. Cancer Vaccines - Innovations
  • 18. Cancer Vaccines- Innovations

4. TRENDS ACROSS CANCER IMMUNOTHERAPY

Trends Across Cancer Immunotherapy

  • 1. Current Industry Trends
  • 2. Venture capital investment
  • 3. Top Venture Capital Investments (2014-2015)
  • 4. Partnerships and Collaborations
  • 5. Partnerships and Collaborations
  • 6. Worldwide Landscape
  • 7. Patent Publishing Trends, Global, 2012-2014
  • 8. Patents per Source Jurisdiction (Top 20 Patent offices), Global, 2012-2014
  • 9. Competitive Benchmarking of Top Patent holders
  • 10. Key Contacts
  • 11. Key Contacts
  • 12. Legal Disclaimer

5. THE FROST & SULLIVAN STORY

The Frost & Sullivan Story

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition: Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top